NEW YORK (GenomeWeb News) – Silicon Valley Biosystems, a company that provides genomic data at the point of care, has been launched.

The Foster City, Calif.-based firm was launched today with financial backing from venture capital firm Sequoia Capital to provide turnkey genomics interpretation services to clinicians "to make faster, more precise, and cost-saving decisions," according to SV Bio.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.